PT1559430E - Utilização de complexos de ginkgo para potenciar as funções cognitivas e aliviar a fadiga mental - Google Patents
Utilização de complexos de ginkgo para potenciar as funções cognitivas e aliviar a fadiga mental Download PDFInfo
- Publication number
- PT1559430E PT1559430E PT04001937T PT04001937T PT1559430E PT 1559430 E PT1559430 E PT 1559430E PT 04001937 T PT04001937 T PT 04001937T PT 04001937 T PT04001937 T PT 04001937T PT 1559430 E PT1559430 E PT 1559430E
- Authority
- PT
- Portugal
- Prior art keywords
- mental fatigue
- enhancement
- ginkgo
- memory
- cognitive
- Prior art date
Links
- 230000003920 cognitive function Effects 0.000 title abstract 4
- 241000218628 Ginkgo Species 0.000 title abstract 3
- 235000011201 Ginkgo Nutrition 0.000 title abstract 3
- 235000008100 Ginkgo biloba Nutrition 0.000 title abstract 3
- 208000019914 Mental Fatigue Diseases 0.000 title abstract 3
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 abstract 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000036651 mood Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Medical Informatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04001937A EP1559430B1 (en) | 2004-01-29 | 2004-01-29 | Use of ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1559430E true PT1559430E (pt) | 2009-06-16 |
Family
ID=34639409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT04001937T PT1559430E (pt) | 2004-01-29 | 2004-01-29 | Utilização de complexos de ginkgo para potenciar as funções cognitivas e aliviar a fadiga mental |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8591965B2 (pt) |
| EP (1) | EP1559430B1 (pt) |
| JP (1) | JP5300196B2 (pt) |
| KR (2) | KR101249633B1 (pt) |
| CN (1) | CN1913907B (pt) |
| AT (1) | ATE428312T1 (pt) |
| AU (1) | AU2005210091B2 (pt) |
| CA (1) | CA2554760C (pt) |
| DE (1) | DE602004020574D1 (pt) |
| DK (1) | DK1559430T3 (pt) |
| ES (1) | ES2323864T3 (pt) |
| HK (1) | HK1098380A1 (pt) |
| IL (1) | IL177118A (pt) |
| NO (1) | NO331190B1 (pt) |
| PL (1) | PL219337B1 (pt) |
| PT (1) | PT1559430E (pt) |
| RU (1) | RU2368385C2 (pt) |
| SG (1) | SG172727A1 (pt) |
| SI (1) | SI1559430T1 (pt) |
| WO (1) | WO2005074956A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100723609B1 (ko) * | 2006-04-28 | 2007-06-04 | 주식회사 유유 | 신규한 조성의 알츠하이머형 치매 및 파킨슨씨병 예방 또는 치료용 은행잎 추출물, 그리고 은행잎으로부터의 추출 및 정제 방법 |
| HUE041715T2 (hu) * | 2007-12-21 | 2019-05-28 | Dr Willmar Schwabe Gmbh & Co Kg | Ginkgo biloba levél-kivonat alkalmazása |
| ITTO20080532A1 (it) * | 2008-07-10 | 2010-01-11 | Euro Pharma S R L | Integratore dietetico atto al potenziamento neuronale e sensoriale |
| IT1397386B1 (it) * | 2010-01-12 | 2013-01-10 | Indena Spa | Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso. |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| CN103156022B (zh) * | 2011-12-09 | 2014-12-17 | 四川科伦药物研究有限公司 | 一种银杏叶保健茶及其制备方法 |
| AU2015348010B2 (en) * | 2014-11-20 | 2020-02-27 | Frutarom Limited | Phospholipid preparations for the improvement of communication skills |
| EP3443965A4 (en) | 2016-04-15 | 2020-02-19 | Hirokawa, Yoshihiro | MEANS FOR HEALING THE COGNITIVE FUNCTION |
| CN105901649A (zh) * | 2016-05-03 | 2016-08-31 | 王胜 | 一种含银杏提取物的植物盐及其制备方法 |
| RU2680809C2 (ru) * | 2016-12-20 | 2019-02-27 | федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) | Способ получения наноразмерной фитосомальной системы |
| US20200226948A1 (en) * | 2019-01-14 | 2020-07-16 | Robert Warren | Time and Attention Evaluation System |
| MX2022008258A (es) * | 2020-01-03 | 2022-08-11 | Biosearch S A | Composicion para usar en el tratamiento de trastornos cognitivos. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2929959A1 (de) * | 1979-07-24 | 1981-02-19 | Hoechst Ag | Thermoplastische kunststoffmasse |
| IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
| IT1238684B (it) * | 1990-02-09 | 1993-09-01 | Indena Spa | Derivati del bilobalide,loro usi e formulazioni che li contegono |
| AU3008301A (en) * | 1999-12-17 | 2001-06-25 | Pharmaton S.A. | Combination of ginseng and ginkgo to improve cognitive skills |
| US6733797B1 (en) * | 2000-11-15 | 2004-05-11 | William K. Summers | Neuroceutical for improving memory and cognitive abilities |
| KR20020069539A (ko) * | 2001-02-26 | 2002-09-05 | 주식회사 두산 | 뇌세포 보호용 조성물 |
| WO2003013549A2 (de) * | 2001-08-09 | 2003-02-20 | Degussa Food Ingredients Gmbh | Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern |
| JP2003169632A (ja) * | 2001-12-08 | 2003-06-17 | Sapuri:Kk | 米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品 |
| JP2003261456A (ja) * | 2002-03-08 | 2003-09-16 | Howaizu:Kk | 脳の老化予防剤 |
| US6572899B1 (en) * | 2002-07-03 | 2003-06-03 | Vitacost.Com, Inc. | Memory loss treatment formulation |
-
2004
- 2004-01-29 PT PT04001937T patent/PT1559430E/pt unknown
- 2004-01-29 DE DE602004020574T patent/DE602004020574D1/de not_active Expired - Lifetime
- 2004-01-29 ES ES04001937T patent/ES2323864T3/es not_active Expired - Lifetime
- 2004-01-29 SI SI200431142T patent/SI1559430T1/sl unknown
- 2004-01-29 EP EP04001937A patent/EP1559430B1/en not_active Expired - Lifetime
- 2004-01-29 AT AT04001937T patent/ATE428312T1/de active
- 2004-01-29 DK DK04001937T patent/DK1559430T3/da active
-
2005
- 2005-01-26 KR KR1020067015129A patent/KR101249633B1/ko active IP Right Grant
- 2005-01-26 WO PCT/EP2005/000738 patent/WO2005074956A1/en active Application Filing
- 2005-01-26 PL PL380826A patent/PL219337B1/pl unknown
- 2005-01-26 JP JP2006550086A patent/JP5300196B2/ja active Active
- 2005-01-26 AU AU2005210091A patent/AU2005210091B2/en active Active
- 2005-01-26 SG SG2011046141A patent/SG172727A1/en unknown
- 2005-01-26 KR KR1020117024637A patent/KR101249667B1/ko active IP Right Grant
- 2005-01-26 RU RU2006127272/15A patent/RU2368385C2/ru active
- 2005-01-26 CA CA2554760A patent/CA2554760C/en active Active
- 2005-01-26 CN CN2005800033273A patent/CN1913907B/zh active Active
- 2005-01-26 US US10/587,468 patent/US8591965B2/en active Active
-
2006
- 2006-07-27 NO NO20063463A patent/NO331190B1/no unknown
- 2006-07-27 IL IL177118A patent/IL177118A/en active IP Right Grant
-
2007
- 2007-05-10 HK HK07104973.6A patent/HK1098380A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20080226757A1 (en) | 2008-09-18 |
| US8591965B2 (en) | 2013-11-26 |
| IL177118A0 (en) | 2008-03-20 |
| CN1913907B (zh) | 2011-03-30 |
| HK1098380A1 (en) | 2007-07-20 |
| SG172727A1 (en) | 2011-07-28 |
| NO20063463L (no) | 2006-07-27 |
| PL380826A1 (pl) | 2007-03-19 |
| WO2005074956A1 (en) | 2005-08-18 |
| NO331190B1 (no) | 2011-10-31 |
| DK1559430T3 (da) | 2009-07-20 |
| CA2554760A1 (en) | 2005-08-18 |
| RU2368385C2 (ru) | 2009-09-27 |
| IL177118A (en) | 2011-03-31 |
| KR20110123289A (ko) | 2011-11-14 |
| JP2007519668A (ja) | 2007-07-19 |
| KR101249667B1 (ko) | 2013-04-02 |
| DE602004020574D1 (de) | 2009-05-28 |
| ES2323864T3 (es) | 2009-07-27 |
| SI1559430T1 (sl) | 2009-08-31 |
| AU2005210091B2 (en) | 2010-06-03 |
| ATE428312T1 (de) | 2009-05-15 |
| JP5300196B2 (ja) | 2013-09-25 |
| CN1913907A (zh) | 2007-02-14 |
| EP1559430B1 (en) | 2009-04-15 |
| AU2005210091A1 (en) | 2005-08-18 |
| KR20060130148A (ko) | 2006-12-18 |
| EP1559430A1 (en) | 2005-08-03 |
| RU2006127272A (ru) | 2008-02-10 |
| KR101249633B1 (ko) | 2013-04-02 |
| CA2554760C (en) | 2018-10-09 |
| PL219337B1 (pl) | 2015-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL177118A0 (en) | Use of a gingo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue | |
| IL170476A (en) | Use of silo-inositol to prepare a drug for the treatment or prevention of Alzheimer's disease, dementia, cognitive impairment and use of the drug to diagnose the presence of abnormal proteins | |
| WO2006035237A3 (en) | Methods and compositions relating to alzheimer's disease | |
| BRPI0416799A (pt) | sistema de orientação de sono e métodos relacionados | |
| HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| EP1979324A4 (en) | IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF COGNITIVE DISORDER, MORBUS ALZHEIMER, NEURODEGENERATION AND DEMENTIA. | |
| IL177787A0 (en) | 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease | |
| MXPA03010843A (es) | Uso de derivados con azetidinona en el tratamiento de enfermedad de alzheimer. | |
| WO2005053719A3 (en) | Compositions for the treatment of diseases of the oral cavity and upper respiratory tract | |
| DE60230961D1 (de) | Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung | |
| WO2004077938A3 (en) | Novel chemical entities and methods for their use in treatment of metabolic disorders | |
| DE60009145D1 (de) | Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen | |
| HK1091657A1 (en) | Use of pyrazolopyridines for the treatment of cognitive deficits | |
| MX2010008706A (es) | Derivados de fenil-prenilo, de origen marino y sintetico. para el tratamiento de enfermedades o trastornos cognitivos, neurodegenerativos o neuronales. | |
| USD562612S1 (en) | Infant carrier cover | |
| Cox et al. | The impact of caregiving for a relative with Alzheimer's disease: A comparison of those caring for persons living alone, spousal caregivers, and co-resident adult children. | |
| Sims | Coyte, Mary Ellen, Peter Gilbert and Vicky Nicholls (eds.). 2007. Spirituality, Values and Mental Health: Jewels for the Journey | |
| Purdon et al. | Selective serotonin reuptake inhibitor modulation of clozapine effects on cognition in schizophrenia. | |
| Mero | Asperger Syndrome With Emotional Disorder—Treatment With Psychoanalytic Psychotherapy | |
| Hirsch | From helplessness to betrayal to the illusion of strength. | |
| Vanka et al. | Caries prevention: A global strategy | |
| Campbell | Sensing disability in Buddhism | |
| 久保光徳 et al. | Evaluation of Pleasure in Riding on a Car Seat | |
| FI20065414A0 (fi) | Maitopohjaisia elintarvikkeita, jotka sisältävät keskushermoston lipidejä | |
| Greenbaum | " Interviewing prepubertal children about suicidal ideation and behavior": Comment. |